Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.99

+2.4%

11:02 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (22241)	6/15/1998 12:21:00 AM
From: Pseudo Biologist	Read Replies (7) of 32384

Ligand's second approved drug, after ONTAK, is likely to be Panretin(R) Gel as a treatment for Kaposi sarcoma; how big is this first market, how fast is it growing? The following abstract ncbi.nlm.nih.gov and a piece published in the May 1998 issue of "Skin & Allergy News," and available at the Medscape site, suggest that this condition is becoming increasingly rare. Not too surprising given what has happened with CMV retinitis over the last few years. Still, if there is a dermatologist in the house, it would be interesting to see how widespread are the observations made in the above two references. PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next